147 related articles for article (PubMed ID: 22120759)
21. Sublingual administration of Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against influenza virus infection in mice.
Lee YN; Youn HN; Kwon JH; Lee DH; Park JK; Yuk SS; Erdene-Ochir TO; Kim KT; Lee JB; Park SY; Choi IS; Song CS
Antiviral Res; 2013 May; 98(2):284-90. PubMed ID: 23523767
[TBL] [Abstract][Full Text] [Related]
22. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
[TBL] [Abstract][Full Text] [Related]
23. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
[TBL] [Abstract][Full Text] [Related]
24. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
25. Studies on the usefulness of intranasal inactivated influenza vaccines.
Tamura S
Vaccine; 2010 Aug; 28(38):6393-7. PubMed ID: 20493820
[TBL] [Abstract][Full Text] [Related]
26. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
[TBL] [Abstract][Full Text] [Related]
27. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
Quan FS; Compans RW; Cho YK; Kang SM
Vaccine; 2007 Jan; 25(2):272-82. PubMed ID: 16945454
[TBL] [Abstract][Full Text] [Related]
28. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity.
Arulanandam BP; O'Toole M; Metzger DW
J Infect Dis; 1999 Oct; 180(4):940-9. PubMed ID: 10479116
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.
Waki N; Yajima N; Suganuma H; Buddle BM; Luo D; Heiser A; Zheng T
Lett Appl Microbiol; 2014 Jan; 58(1):87-93. PubMed ID: 24329975
[TBL] [Abstract][Full Text] [Related]
30. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
31. Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice.
Park S; Kim JI; Bae JY; Yoo K; Kim H; Kim IH; Park MS; Lee I
J Microbiol; 2018 Feb; 56(2):145-149. PubMed ID: 29392562
[TBL] [Abstract][Full Text] [Related]
32. Anti-influenza virus effects of the aqueous extract from Mosla scabra.
Yu C; Yan Y; Wu X; Zhang B; Wang W; Wu Q
J Ethnopharmacol; 2010 Feb; 127(2):280-5. PubMed ID: 19914366
[TBL] [Abstract][Full Text] [Related]
33. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
34. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
[TBL] [Abstract][Full Text] [Related]
36. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
[TBL] [Abstract][Full Text] [Related]
37. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
[TBL] [Abstract][Full Text] [Related]
38. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.
Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
Cytokine; 2006 Dec; 36(5-6):254-60. PubMed ID: 17363262
[TBL] [Abstract][Full Text] [Related]
39. Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model.
Kawahara T; Takahashi T; Oishi K; Tanaka H; Masuda M; Takahashi S; Takano M; Kawakami T; Fukushima K; Kanazawa H; Suzuki T
Microbiol Immunol; 2015 Jan; 59(1):1-12. PubMed ID: 25400245
[TBL] [Abstract][Full Text] [Related]
40. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.
Kashima Y; Ikeda M; Itoh Y; Sakoda Y; Nagata T; Miyake T; Soda K; Ozaki H; Nakayama M; Shibuya H; Okamatsu M; Ishigaki H; Ishida H; Sawai T; Kawaoka Y; Kida H; Ogasawara K
Vaccine; 2009 Dec; 27(52):7402-8. PubMed ID: 19747993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
